TABLE 1.
Strains | Descriptiona | Reference or source |
---|---|---|
E. coli | ||
JM110 | E. coli cloning host | 39 |
DH5α | E. coli cloning host | Gibco-BRL |
MC1061 | E. coli host for pNZ18 | 4 |
BIL21 (DE3) | Expression host for pET28a | Novagen |
L. lactis subsp. lactis NCK203 | Sensitive host for phage φ31 | 15 |
Plasmids | ||
pT7Blue | Apr; T-vector for cloning PCR products | Novagen |
pTRK390 | Emr; lactococcal promoter screening vector | 27 |
pTRK391 | Emr; pTRK390::P15A10 | 27 |
pTRK477 | Emr; pTRK390::P566–888 | This study |
pTRK486 | Emr; pTRK390::P566–862 | This study |
pTRK481 | Emr; pTRK390::P566–849 | This study |
pTRK485 | Emr; pTRK390::P566–792 | This study |
pTRK487 | Emr; pTRK390::P566–732 | This study |
pTRK483 | Emr; pTRK390::P566–888S | This study |
pTRK482 | Emr; pTRK390::P566–862S | This study |
pTRK484 | Emr; pTRK390::P15A10/mutORF2 | This study |
pET28a | Knr; E. coli expression vector (T7 based) | Novagen |
pTRK478 | Knr; pET28a::ORF2 | This study |
pNZ18 | Cmr; high-copy-number shuttle vector | 8 |
pTRK452 | Cmr; pNZ18::P566–888::ORF2 | This study |
pTRK479 | Cmr; pNZ18::P6::antiORF2::TT7 | This study |
pTRK360 | Cmr, Emr; pSA3 + ori31 | 26 |
pTRK392 | Cmr, Emr; pTRK360::P15A10:: lacZ.st | 27 |
pTRK480 | Cmr, Emr; pTRK360::P566–862S:: lacZ.st | This study |
pCITE4a | Apr; for in vitro transcription-translation | Novagen |
Abbreviations: Apr, ampicillin resistance; Emr, erythromycin resistance; Cmr, chloramphenicol resistance; Knr, kanamycin resistance.